CAP Molecular Diagnosis of Lung Cancer
List 5 treatment defining molecular transformation, the neoplasm, and the genetic alteration
|
---|
1. 100% of CML: BRR-ABL > Imatinib, 2. 20% of Lung Adenocarcinoma: EGFR > Erlotinib/Gefitinib, 3. 25% Infiltrative ductal carcinoma of breast HER2>Trastuzumab, 4. 50% of Melanoma, BRAF v600E > PLX4032, 5. 4% of Lung Adenocarcinoma: ALK > Crizotinib |
List and describe 5 areas of Genetic characaterization of tumours for personalized medicine
|
---|
DNA mutations, DNA chromosomal alterations, mRNA and MiRNA profiling, Proteomics, DNA epigenetics |
What fraction of Lung adenocarcinomas have no known detactable mutations
|
---|
42% |
What are the three most common molecular alterations of Lung Adenocarcinoma
|
---|
KRAS 23%, EGFR 15%, TP53 5% |
What is the two most common molecular alteration makes patients with EGFR mutations resistant to targetted therapies?
|
---|
KRAS (primary) and T790M (primary and acquired) |
List two EGFR kinase inhibitors.
|
---|
Gefitinib/Iressa, Erlotinib/Tarceva |
What are the three most common cancers associated with KRAS mutations?
|
---|
Pancreatic 90%, Colon 50%, Lung NSCLC 30% |
Why don't KRAS + tumours respond to Anti EGFR therapies?
|
---|
KRAS is downstream from EGFR, so changing the function of EFGR would not have any effect on mutated KRAS |
Explain the cost effectiveness of genetic testing for targetted therapies?
|
---|
Most molecular tests cost $200-1000, vs one month of targetted therapy $2000-10000/month |
What are the three most common cancers associated with BRAF mutations?
|
---|
Melanoma 70%, Papillary Thyroid Carcinoma 50%, Ovarian serious carcinoma 30%, Colon cancer 10%, Hint Papillary architecture |
Beta catenin/CTNNB1 expression is found with which histological pattern of lung adenocarcinoma?
|
---|
Low grade adenocarcinoma of fetal type, poor px, <40yo, and has glycogen rich glandular formations, may occur in FAP patients |
What is the most common ALK rearrangement found in NSCLC?
|
---|
EML4-ALK (90% of the 13% of lung cancers found to due to ALK fusions) |
List some pros and cons of ALK FISH.
|
---|
Pros: commercial FDA approved probes available, not too expensive, moderately easy to disseminate screening, clinically validated, and failed tests on poorly preserved tissues are not reported as negative. Cons: need fish lab expertise (including pathologist and PhD), can be tricky if genes are close |
List some pros and cons of ALK IHC.
|
---|
Pros: fast, cheap, easy to disseminate screening, Cons: commercial antibodies sub-optimal, poorly preserved tissues (esp bx) may give false negative results due to loss of antigenicity, no internal control |
What is a positive count in the ALK-FISH?
|
---|
Signal split >2 probe diameters |